These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19454675)

  • 1. Teleost B7 expressed on monocytes regulates T cell responses.
    Sugamata R; Suetake H; Kikuchi K; Suzuki Y
    J Immunol; 2009 Jun; 182(11):6799-806. PubMed ID: 19454675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The B7 family of immunoregulatory receptors: a comparative and evolutionary perspective.
    Hansen JD; Du Pasquier L; Lefranc MP; Lopez V; Benmansour A; Boudinot P
    Mol Immunol; 2009 Jan; 46(3):457-72. PubMed ID: 19081138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.
    Chapoval AI; Ni J; Lau JS; Wilcox RA; Flies DB; Liu D; Dong H; Sica GL; Zhu G; Tamada K; Chen L
    Nat Immunol; 2001 Mar; 2(3):269-74. PubMed ID: 11224528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection of B7-1 cDNA empowers antigen presentation of blood malignant cells for activation of anti-tumor T cells.
    Ke X; Jia L; Wang J; Wang D
    Chin Med J (Engl); 2003 Jan; 116(1):78-84. PubMed ID: 12667394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular epithelial expression of the coinhibitory molecule B7-DC (programmed death-1 ligand).
    Zhang J; Chen Y; Li J; Zhang R; Wu Y; Zou L; Zhao T; Zhang X; Han J; Chen A; Wu Y
    J Nephrol; 2006; 19(4):429-38. PubMed ID: 17048200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response.
    Seo SK; Seo HM; Jeong HY; Choi IW; Park YM; Yagita H; Chen L; Choi IH
    Immunol Lett; 2006 Feb; 102(2):222-8. PubMed ID: 16236366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties.
    Bhatia S; Edidin M; Almo SC; Nathenson SG
    Immunol Lett; 2006 Apr; 104(1-2):70-5. PubMed ID: 16413062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells in teleost fish act as pivotal initiating APCs in priming adaptive immunity: an evolutionary perspective on the origin of the B-1 cell subset and B7 molecules.
    Zhu LY; Lin AF; Shao T; Nie L; Dong WR; Xiang LX; Shao JZ
    J Immunol; 2014 Mar; 192(6):2699-714. PubMed ID: 24532580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new B7s: playing a pivotal role in tumor immunity.
    Flies DB; Chen L
    J Immunother; 2007 Apr; 30(3):251-60. PubMed ID: 17414316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of the costimulatory molecules CD80, CD86, CD152, PD-1 and ICOS on T-cells from paracoccidioidomycosis patients: lack of correlation with T-cell hyporesponsiveness.
    Cacere CR; Mendes-Giannini MJ; Fontes CJ; Kono A; Duarte AJ; Benard G
    Clin Immunol; 2008 Nov; 129(2):341-9. PubMed ID: 18757242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of T cell responses after cross-talk between antigen presenting cells and T cells: a give-and-take relationship.
    Wauben MH; 't Hoen EN; Taams LS
    Novartis Found Symp; 2003; 252():211-20; discussion 220-5, 257-67. PubMed ID: 14609221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential T cell expansion by artificial antigen presenting cells expressing 4-1BBL alone or in combination with CD80 or CD86.
    Habib-Agahi M; Jaberipour M; Phan TT; Searle PF
    Iran J Immunol; 2008 Sep; 5(3):136-47. PubMed ID: 18791280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of B7-2 in tumor cells of Hodgkin's disease.
    Bosshart H
    Immunol Lett; 2004 Apr; 92(3):217-20. PubMed ID: 15081615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The B7 family and cancer therapy: costimulation and coinhibition.
    Zang X; Allison JP
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5271-9. PubMed ID: 17875755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1.
    Bauvois B; Nguyen J; Tang R; Billard C; Kolb JP
    Biochem Pharmacol; 2009 Sep; 78(5):514-22. PubMed ID: 19433065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells.
    Compte E; Pontarotti P; Collette Y; Lopez M; Olive D
    Eur J Immunol; 2004 Aug; 34(8):2089-99. PubMed ID: 15259006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.
    Zhang G; Hou J; Shi J; Yu G; Lu B; Zhang X
    Immunology; 2008 Apr; 123(4):538-46. PubMed ID: 18194267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer.
    Loos M; Giese NA; Kleeff J; Giese T; Gaida MM; Bergmann F; Laschinger M; W Büchler M; Friess H
    Cancer Lett; 2008 Sep; 268(1):98-109. PubMed ID: 18486325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antigen driven lymphocyte proliferation secondary to GP41-induced B7 expression on adherent monocytes.
    Kolber MA; Saenz MO
    Cell Immunol; 2001 Nov; 214(1):35-44. PubMed ID: 11902827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.